University College Hospital. Hormone therapy for prostate cancer. Radiotherapy Department Patient information series



Similar documents
University College Hospital. Prostate high dose rate (HDR) brachytherapy. Radiotherapy Department Patient information series

University College Hospital. Stereotactic ablative body radiotherapy (SABR) for lung cancer. Radiotherapy Department Patient information series

Hormonal therapy for advanced prostate cancer

University College Hospital. Metastatic spinal cord compression (MSCC) information for patients at risk of developing MSCC.

Information for patients receiving short-term hormone treatment and radiotherapy for prostate cancer

Advanced prostate cancer

Advanced prostate cancer

Patient & Family Guide 2015 Hormone Therapy for Prostate Cancer

Hormone therapy. In this fact sheet: How does hormone therapy treat prostate cancer? What happens next?

Radiation Therapy for Prostate Cancer

Hormone Therapy and Prostate Cancer

Living with hormone therapy. A guide for men with prostate cancer

Locally advanced prostate cancer

Transrectal Ultrasound (Trus) Guided Prostate Biopsies Urology Patient Information Leaflet

Information for Men Receiving Radiation and Hormone Treatments for Prostate Cancer

Prostate cancer A guide for newly diagnosed men

Male menopausal symptoms during and after cancer treatment

Temozolomide (oral) with concurrent radiotherapy to the brain

Living with hormone therapy A guide for men with prostate cancer

Recurrent prostate cancer A guide to treatment and support

University College Hospital. Radiotherapy to the adult spine. Radiotherapy Department Patient information series

Testosterone & Testosterone Replacement Therapy

X-Plain Low Testosterone Reference Summary

Understanding Locally-Advanced Prostate Cancer

Prostate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH).

How is Prostate Cancer Diagnosed?

Patient information. Goserelin Zoladex Breast Services Directorate PIF 1005 V3

Radiotherapy for vulval cancer

Treating Prostate Cancer

Radiotherapy to the chest wall

University College Hospital. Contrast agent for radiotherapy CT (computed tomography) scans. Radiotherapy Department Patient information series

Kent Oncology Centre Radiotherapy Side Effects and Management: Breast and Chest Wall Information for patients Maidstone Hospital

Treating Localized Prostate Cancer A Review of the Research for Adults

Breast Cancer Questions to Ask

The Radiotherapy Department Radiotherapy to the breast Information for patients

How To Deal With The Side Effects Of Radiotherapy

Localised prostate cancer

University College Hospital. Radiotherapy to the breast. Radiotherapy Department Patient information series

University College Hospital. Having total body irradiation (TBI) Radiotherapy Department Patient information series

Dynamic prostate brachytherapy

KELOWNA PROSTATE CANCER SUPPORT & AWARENESS GROUP NEWSLETTER

A start to help you understand prostate cancer

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

Prostate Brachytherapy Low dose rate permanent seed implant

Understanding the PSA test. A guide for men concerned about prostate cancer

A guide to prostate cancer clinical trials

Treatment for bladder tumours - transurethral resection of a bladder tumour (TURBT)

An Introduction to PROSTATE CANCER

External beam radiotherapy

Prostate Cancer Screening. A Decision Guide for African Americans

The Radiotherapy Department Radiotherapy to the chest wall and lymph nodes

Radiotherapy for a mesothelioma

How prostate cancer is diagnosed

BRCA1 and BRCA2 for men

Prostate Cancer Screening. A Decision Guide

Living with hormone therapy A guide for men with prostate cancer

Physical therapies. Massage

PSA Screening for Prostate Cancer Information for Care Providers

Radioactive iodine treatment for thyroid cancer

Follow-up after prostate cancer treatment What happens next?

Radiotherapy for breast cancer

The RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial of treatment after surgery for prostate cancer

Advanced prostate cancer

Early Prostate Cancer: Questions and Answers. Key Points

Salisbury Lung Cancer Service (1 of 5)

Treatment for pleural mesothelioma

Factsheet No.10. Testicular Cancer. Testosterone replacement therapy for men following testicular cancer treatment

Basics on Treatment for prostate cancer

Sex, erectile dysfunction and prostate cancer

Prostate cancer. A guide for men who ve just been diagnosed

Prostate Cancer. Understanding your diagnosis

Southampton breast care support. Your guide to life after breast cancer in men Information for patients

WHEN PROSTATE CANCER RETURNS: ADVANCED PROSTATE CANCER. How Will I Know If My Prostate Cancer Returns?

ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits

Chemotherapy. What is chemotherapy? How does it work? What is cancer? How will I be given chemotherapy? Cannula

Drug treatments for kidney cancer

Short Course, Pre-operative Radiotherapy for Bowel Cancer

BREAST CANCER TREATMENT

Guy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Maintenance BCG for nonmuscle invasive bladder cancer

Prostate Specific Antigen (PSA) Blood Test

Life after treatment for Lung Cancer

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

Prostate Cancer Information and Facts

Breast Cancer. Breast Cancer Page 1

CONTENTS: WHAT S IN THIS BOOKLET

Secondary liver cancer Patient Information Booklet

Treating Oesophageal Cancer A Quick Guide

Invasive lobular breast cancer

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

Edinburgh Breast Unit

Getting checked for Prostate Cancer

How to Improve Bladder After Bowler Cancer

Treating Mesothelioma - A Quick Guide

People Living with Cancer

UCLH. Transurethral resection of bladder tumour (TURBT) Urology Directorate

Secondary breast cancer in the brain Factsheet

Ask your healthcare provider about LONG-ACTING AVEED (testosterone undecanoate) AVEED TESTOSTERONE INJECTION 5 SHOTS A YEAR. Not an actual patient.

Dealing with Erectile Dysfunction During and After Prostate Cancer Treatment For You and Your Partner

Radiotherapy: English. Radiotherapy

Transcription:

University College Hospital Hormone therapy for prostate cancer Radiotherapy Department Patient information series 10

2 If you need a large print, audio or translated copy of the document, please contact us on: 020 3447 3711 (Direct line) 020 3456 7890 ext 73711/bleep 1458 0845 155 5000 ext 73711/bleep 1458 We will try our best to meet your needs.

3 Contents Introduction 5 What are hormones? 5 What is hormone therapy? 6 How and when is hormone therapy prescribed? 7 Side effects of hormone therapy 7 Useful contact numbers 9

4

5 Introduction This booklet has been written for male patients who have been recommended hormone therapy for prostate cancer. This booklet explains: What are hormones. What is hormone therapy. The side effects you may experience during hormone therapy, and how best to cope with them. We understand that this is a daunting time for patients. You may feel that you have been given lots of information about what needs to be done in a short period of time. We hope this booklet answers some of your questions. If you still have any questions or concerns, please let your doctor or specialist nurse know. They are here for you and are in the best position to help and advise you. What are hormones? Hormones are substances that occur naturally in your body. They act as chemical messengers and help control the growth and activity of cells and organs. Testosterone (the male sex hormone) is made mainly in the testicles, but a small amount also comes from the adrenal glands (which sit on top of the kidneys). As part of the male reproductive system, the prostate gland needs testosterone in order to grow. Similarly, prostate cancer is also dependent on testosterone for its growth. Therefore, if the level of testosterone is reduced, it is possible to slow the growth of the cancer and even cause it to shrink. The PSA (Prostatic Specific Antigen) level in your blood may drop and sometimes the symptoms of prostate cancer, such as bone pain and difficulty in passing urine, may disappear. The level of testosterone can be reduced by drugs (hormone therapy) or surgery (the removal of the testicles). Hormone therapy is now more commonly used as an alternative to surgery.

6 What is hormone therapy? Hormone therapy is the use of injections and/or tablets to alter the production or activity of other hormones in the body. In the case of prostate cancer, it is to reduce the level of testosterone. There are two main types of drugs used in hormone therapy for prostate cancer. These are called pituitary down-regulators and anti-androgens. Pituitary down-regulators The testicles make testosterone because a hormone (called luteinising hormone) released by the pituitary gland in the brain tells them to. These drugs block that hormone. So the testicles do not receive the message and therefore testosterone production is switched off. One example of such a drug is goserelin acetate or Zoladex. Zoladex is given by an injection under the skin of your abdomen either once a month or once every three months. It can be given by your GP or practice nurse at the GP surgery, or a district nurse if you are unable to visit the GP. Some people find the injection a little uncomfortable, and you may notice some slight bruising around the injection site afterwards. If you request it, a tiny amount of anaesthetic cream can be used on the skin to numb the area before the injection. Anti-androgens These drugs block the effects of the testosterone from your testicles and adrenals, they do not reduce the amount of testosterone. On the surface of the prostate cancer cells there are proteins called receptors. These receptors act as a lock, so when testosterone comes into contact with them they unlock or activate the cancer cells to grow. The antiandrogens attach themselves to the receptors thus blocking the testosterone, so the cancer cell cannot grow. One example of such a drug is bicalutamide or Casodex. Casodex is usually taken daily in tablet form before and at the beginning of the Zoladex injections.

7 How and when is hormone therapy prescribed? Hormone therapy is often used in the following situations: Localised prostate cancer used temporarily alongside surgery, external beam radiotherapy or brachytherapy. Localised prostate cancer used long-term instead of the above treatments, because of the patient s choice. Recurrent prostate cancer because neither radical prostatectomy (the removal of the prostate gland) nor radical radiotherapy (to the prostate) can be repeated. Metastatic prostate cancer. How you will be given the hormone therapy and for how long depends on the grade and stage of your tumour, your age and general health. It is often given for several months or several years. Your doctor will discuss the best choice of hormone therapy for you. Side effects of hormone therapy There are some side effects common to all hormone therapies used for prostate cancer, and some that vary from drug to drug. You may experience only a few side effects, while others experience more. All patients are unique. These side effects are temporary and generally reversible once the hormone therapy is stopped. Possible side effects may include: Hot flushes They are caused by your testosterone levels dropping. They may get better as you get used to treatment. However, in some men the flushes keep on as long as the drug is taken. If they are troublesome, please speak to your doctor, specialist nurse, the radiographers or nurses. There are treatments available to reduce these side effects.

8 Tumour flare After the first Zoladex injection there may be a temporary increase in the production of testosterone. Because of this, some men may find that they experience an increase in symptoms such as bone pain or urinary obstruction. An anti-androgen tablet will be given for a few weeks before the first injection to prevent this from occurring. Loss of sex drive and impotence (inability to get an erection) This is a major side effect of hormone therapy. You will lose your sex drive and be impotent as long as you are taking drugs such as Zoladex. This is because you are not producing any testosterone. You may regain your potency if the treatment stops. This can take several months, however, from when treatment stops, depending on the drug you are having and how long you have been taking it. Some men keep their sex drive and ability to maintain an erection when taking Casodex alone, but there is a risk of becoming impotent with long-term treatment. About one in five men keep their ability to get an erection, even with long-term treatment. Your doctor can discuss this more fully with you, and also discuss treatments available for impotence. Fatigue Long-term hormone therapy can cause you to have a low level of iron in your blood. This can make you tired and breathless. You may have blood tests from time to time to check the iron levels in your blood. Weight gain and some loss of muscle bulk you should be able to control both by eating a healthy diet and taking gentle exercise. Advice about dieting can be had from your GP or ask to see a dietician. Before starting any exercise regime please seek medical advice. Swelling and tenderness of the breast tissue (gynaecomastia) This is a common side effect of hormone therapy. The breasts can become tender and slightly enlarged. Other side effects include sore joints and possible mood changes.

9 Useful contact numbers Local Macmillan Information and Support Radiographer Mark Williams Direct telephone: 020 3447 3711 Main switchboard: 0845 155 5000 ext 73711 bleep 1458 Alternative switchboard: 020 3456 7890 ext 73711 bleep 1458 mark.williams@uclh.nhs.uk Dr Payne s Secretary: Direct telephone: 020 3447 9105 Dr Mitra s Secretary: Direct telephone: 020 3447 9090

10 National Prostate Cancer Support Association Helpline: 0845 601 0766 The Prostate Cancer Charity Freephone Helpline: 0800 074 8383 helpline@prostate cancersupport.info www.prostatecancersupport.co.uk info@prostate-cancer.org.uk www.prostate-cancer.org.uk Prostate Action Telephone: 020 8788 7720 info@prostateaction.org.uk www.prostateaction.org.uk Prostate Cancer Research Centre Telephone: 020 7679 9366 Prostate Cancer Federation National Helpline: 0845 601 0766 info@prostate-cancer-research.org.uk www.prostate-cancer-research.org.uk info@prostatecancerfederation.org.uk www.prostatecancerfederation.org.uk Continence Foundation Telephone: 0845 345 0165 Monday to Friday, 09:30 to 12:30 E-mail: The Impotence Association Telephone: 020 8767 7791 continence-help@dial.pipex.com www.continence-foundation.org.uk info@impotence.org.uk www.impotence.org.uk

11 Macmillan Cancer Support Cancer Line freephone: 0808 808 0000 Monday to Friday, 09:00 to 21:00 Textphone: 0808 808 0121 Monday to Friday, 09:00 to 18:00 cancerline@macmillan.org.uk www.macmillan.org.uk CancerHelp UK Freephone Helpline: 0808 800 4040 Monday to Friday, 9:00 to 17:00 Cancer Research UK www.cancerhelp.org.uk www.cancerresearchuk.org Carers UK Freephone: 0808 808 7777 Wednesday to Thursday Health Talk Online adviceline@carersuk.org www.carersuk.org www.healthtalkonline.org National Library for Health Covers all aspects of health, illness and treatments www.library.nhs.uk NHS Direct Telephone: 0845 4647 Available 24 hours www.nhsdirect.nhs.uk Patient UK Comprehensive, free, up-to-date health information www.patient.co.uk

First published: May 2002 Last review date: June 2013 Next review date: June 2015 Leaflet code: UCLH/S&C/CD/RT/HORMONE/2 University College London Hospitals NHS Foundation Trust Created by Medical Illustration RNTNEH 020 3456 5103 Unique Code: 28881